Informed consent to HIV cure research

Area of Science:

• Medical Ethics
• Clinical Research
• Infectious Diseases

Background:

• HIV cure trials present unique ethical challenges due to unfavorable risk-benefit ratios.
• Participant willingness to enroll in high-risk trials, despite stable health on antiretroviral therapy, necessitates ethical scrutiny.

Purpose of the Study:

• To analyze the quality of informed consent in human immunodeficiency virus (HIV) cure trials.
• To distinguish and evaluate concerns related to information communication, participant motivation, and trial understanding.

Main Methods:

• Conceptual analysis of informed consent principles within the context of high-risk clinical research.
• Distinguishing between validity and quality of decision-making concerning participant consent.

Main Results:

• Communication of information is crucial for informed consent validity and decision-making quality.
• Participant motivation for high-risk research does not invalidate consent or decision quality.
• Understanding trial details is relevant to decision-making quality, though not necessarily consent validity.

Conclusions:

• Guidance is needed for researchers and ethics committees involved in HIV cure trial recruitment.
• Ensuring clear communication and adequate understanding enhances the ethical conduct of HIV cure research.
• Ethical frameworks must address the specific nuances of informed consent in trials with significant participant risk.